BPD@Singapore
The BPD Biopharmaceutical Bioprocess Development Summit is Asia's leading event focused on end-to-end biologics process development and commercialization. 2025 BPD is held across Shanghai, Beijing, Chengdu, and Singapore, featuring both main annual conference and regional forums. The BPD2024 main conference in Shanghai welcomed 5,000 participants from biopharma, biotech, and upstream suppliers, combining exhibition, conference, and networking to drive CMC and chain collaboration. Initiated by Enmore BIO and co-hosted with WuXi XDC, the 2025 BPD Singapore will be held on September 24–26, bringing together top biopharma, pharma and suppliers from China, APAC, Europe, and North America to explore strategies for internationalizing biologics manufacturing.
About WuXi XDC
WuXi XDC Cayman Inc. ( "WuXi XDC" or the“Company”,stock code:2268.HK) is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market.lt provides end-to-end contract research,development and manufacturing services for bioconjugates, including ADCs. lts services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. For more information about WuXi XDC, please visit:www.wuxixdc.com.
About Duoning
Shanghai Duoning Biotechnology Co., Ltd. (“Duoning Biotechnology”) is a leading one-stop bioprocess solutions provider in China, focusing on providing comprehensive solutions for biological products from R&D to commercialization.
About Lisure
LISURE is a one-stop shop for engineering systems for biopharmaceutical industry. With expertise in flow system design, hardware design, control strategy design and quality management, we provide simple and straightforward DSP solutions for customers in the cGMP-regulated industry.
About ANDGEL
Andgel is a leading supplier of core process equipment and total process solution for biotech industry in China. Andgel provides Bio Process Innovative Technical Services, Bio Process EMMACQ® Customized Commercial Bioreactor, Fermenter System and Upstream and Downstream Process System, Pilot PILBIOFER® Standard Bioreactor and Fermenter System, R＆D LABBIOFER® Benchtop Bioreactor and Fermenter, and Microjet NanoSystem.
About Cytiva
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com.cn to learn more.
About Bio-link
BioLink is a group of technology-driven businesses that provide process solutions in the life sciences industry. The company focuses on the development and production of the key process ing equipment and consumables used in the manufacturing process of recombinant protein drugs, vaccines, antibodies, cell therapies, gene therapies, and other biological products. BioLink's products cover the entire bioprocess such as cell culture, single-use mixing and storage, chromatography, filtration, and hydration products, as well as process development services. BioLink is committed to providing customers with high-quality, innovative products and solutions and strives to build an efficient, safe and competitive biopharmaceutical supply chain eco-system.
About Syntegon
Syntegon is pharmaceutical companies’ strategic partner for processing and packaging technology. Its strong workforce delivers seamless processes, innovative technologies, and sustainable solutions to the industry. Syntegon’s integrated lines enable pharmaceutical companies to produce, process, fill, inspect, and package liquid and solid medicines, safely and in high quality. Headquartered in the Stuttgart region, Germany, Syntegon can look back on more than 160 years of experience. With a global presence of more than 47 locations in almost 20 countries and a comprehensive service portfolio, Syntegon provides a platform for seamless processes for its customers. The company’s 1,500 employees in research and development work on leading technologies every day. By providing sustainable solutions, Syntegon enables the industry to switch to alternative packaging and resource-conserving production processes.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
About Morimatsu
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). We are dedicated in providing core equipment, process systems, and smart modular facility solutions, and intelligent digital services for the pharmaceutical, biopharmaceutical, aesthetic medicine, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data center.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe, USA, Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
嘉宾阵容 Speaker Lineup
